We revealed the entire landscape of pathway alterations in breast cancer, which exhibited high mutation frequencies in the p53 (55%), PI3K (45%), RTK-RAS (32%), and Notch (17%) pathways (Fig. 4a). The gene discussed is PIK3CA; the disease is breast carcinoma.